BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24568501)

  • 1. Institutional experience of interstitial brachytherapy for head and neck cancer with a comparison of high- and low dose rate practice.
    Mohanti BK; Sahai P; Thakar A; Sikka K; Bhasker S; Sharma A; Sharma S; Bahadur S
    Asian Pac J Cancer Prev; 2014; 15(2):813-8. PubMed ID: 24568501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997.
    Grabenbauer GG; Rödel C; Brunner T; Schulze-Mosgau S; Strnad V; Müller RG; Iro H; Sauer R
    Strahlenther Onkol; 2001 Jul; 177(7):338-44. PubMed ID: 11505619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer.
    Kakimoto N; Inoue T; Inoue T; Murakami S; Furukawa S; Yoshida K; Yoshioka Y; Yamazaki H; Tanaka E; Shimizutani K
    Radiother Oncol; 2003 Aug; 68(2):123-8. PubMed ID: 12972306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interstitial high-dose rate brachytherapy with iridium-192 in patients with oral squamous cell carcinoma.
    Friedrich RE; Krüll A; Hellner D; Schwarz R; Heyer D; Plambeck K; Schmelzle R
    J Craniomaxillofac Surg; 1995 Aug; 23(4):238-42. PubMed ID: 7560110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer.
    Strnad V; Geiger M; Lotter M; Sauer R
    Brachytherapy; 2003; 2(3):158-63. PubMed ID: 15062138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of HDR (192Ir) versus MDR (137Cs) intracavitary brachytherapy for carcinoma of the uterine cervix.
    Tanaka E; Oh RJ; Yamada Y; Shiomi H; Nakamura S; Shimamoto S; Teshima T; Inoue T; Inoue T
    Brachytherapy; 2003; 2(2):85-90. PubMed ID: 15062145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early results of pulsed-dose-rate interstitial brachytherapy for head and neck malignancies after limited surgery.
    Strnad V; Lotter M; Grabenbauer G; Sauer R
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):27-30. PubMed ID: 10656368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate.
    Levendag PC; Schmitz PI; Jansen PP; Senan S; Eijkenboom WM; Sipkema D; Meeuwis CA; Kolkman-Deurloo IK; Visser AG
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):497-506. PubMed ID: 9231672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx.
    Rudoltz MS; Perkins RS; Luthmann RW; Fracke TD; Green TM; Moye L; Wludyka P; Choi YK; Ackerman SN
    Laryngoscope; 1999 Dec; 109(12):1967-73. PubMed ID: 10591356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical lymph node relapses of head-and-neck squamous cell carcinoma: is brachytherapy a therapeutic option?
    Bollet MA; Lapeyre M; Marchal C; Hoffstetter S; Peiffert D; Cornes PG; Luporsi E; Bey P
    Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1305-12. PubMed ID: 11728691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Salvage therapy of advanced squamous cell carcinoma of the mouth cavity and oropharynx. Results of interstitial high-dose-rate brachytherapy combined with ablative tumor surgery].
    Friedrich RE; Krüll A; Schwarz R; Thurmann H; Plambeck K; Schmelzle R
    Strahlenther Onkol; 1997 Oct; 173(10):507-12. PubMed ID: 9381359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications.
    Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Matsuura K; Ito K
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):767-75. PubMed ID: 10386633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Place of iridium 192 implantation in irradiation of T1-T2 squamous cell carcinoma of the velopharyngeal arch].
    Mazeron JJ; Belkacemi Y; Simon JM; Le Péchoux C; Martin M; Haddad E; Piedbois P; Calitchi E; Strunski W; Peynègre R; Le Bourgeois JP; Pierquin B
    Bull Cancer Radiother; 1996; 83(1):47-53. PubMed ID: 8679281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks.
    Bourhis J; Dendale R; Hill C; Bosq J; Janot F; Attal P; Fortin A; Marandas P; Schwaab G; Wibault P; Malaise EP; Bobin S; Luboinski B; Eschwege F; Wilson G
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):471-6. PubMed ID: 8655369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brachytherapy for early oral tongue cancer: low dose rate to high dose rate.
    Yamazaki H; Inoue T; Yoshida K; Yoshioka Y; Furukawa S; Kakimoto N; Shimizutani K; Inoue T
    J Radiat Res; 2003 Mar; 44(1):37-40. PubMed ID: 12841597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial brachytherapy with or without external beam irradiation in head and neck cancer: Institute Rotary Cancer Hospital experience.
    Mohanti BK; Bansal M; Bahadur S; Shukla NK; Deo SV; Prabhakar R; Rath GK
    Clin Oncol (R Coll Radiol); 2001; 13(5):345-52. PubMed ID: 11716227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial.
    Peters LJ; Goepfert H; Ang KK; Byers RM; Maor MH; Guillamondegui O; Morrison WH; Weber RS; Garden AS; Frankenthaler RA
    Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):3-11. PubMed ID: 8482629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
    Kim WC; Kim GE; Suh CO; Loh JJ
    Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.